LLY vs MDT
By Alex · Tickerpine
Eli Lilly and Company vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | MDT |
|---|---|---|
| Price | $1,208.12 | $80.98 |
| Market cap | $1.08T | $103.66B |
| P/E ratio | 42.9 | 21.7 |
| ROE | 107.46% | 9.84% |
| Profit margin | 34.99% | 13.20% |
| Revenue growth | 55.50% | 9.90% |
| Dividend yield | 0.57% | 3.56% |
| Beta | 0.52 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs MDT in plain English
- LLY is the bigger company — about 10.4× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.7 vs 42.9).
- LLY earns a higher return on equity (107% vs 10%).
- LLY is growing revenue faster (56% vs 10%).
- MDT has the higher dividend yield (3.56% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.